HINOVA PHARMACEUTICALS INC.HINOVA PHARMACEUTICALS INC.HINOVA PHARMACEUTICALS INC.

HINOVA PHARMACEUTICALS INC.

No trades
See on Supercharts
Market capitalization
‪3.75 B‬CNY
−2.12CNY
‪−294.16 M‬CNY
0.00CNY
Beta (1Y)
0.97
Employees (FY)
181
Change (1Y)
+19 +11.73%
Revenue / Employee (1Y)
0.00CNY
Net income / Employee (1Y)
‪−228.91 K‬CNY

About HINOVA PHARMACEUTICALS INC.


CEO
Yuan Wei Chen
Headquarters
Chengdu
Founded
2013
ISIN
CNE1000059F5
FIGI
BBG0115TJ3S0
Hinova Pharmaceuticals, Inc. engages in the research and development of pharmaceutical products. It offers castration-resistant prostate cancer treatment and anti-gout and hyperuricemia drugs. The company was founded by Yuan Wei Chen and Xing Hai Li on February 5, 2013 and is headquartered in Chengdu, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 688302 is 37.90 CNY — it has increased by 0.53% in the past 24 hours. Watch HINOVA PHARMACEUTICALS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange HINOVA PHARMACEUTICALS INC. stocks are traded under the ticker 688302.
688302 stock has fallen by −0.99% compared to the previous week, the month change is a −2.37% fall, over the last year HINOVA PHARMACEUTICALS INC. has showed a −17.59% decrease.
688302 reached its all-time high on May 4, 2023 with the price of 78.77 CNY, and its all-time low was 22.60 CNY and was reached on Jul 5, 2024. View more price dynamics on 688302 chart.
See other stocks reaching their highest and lowest prices.
688302 stock is 5.36% volatile and has beta coefficient of 0.97. Track HINOVA PHARMACEUTICALS INC. stock price on the chart and check out the list of the most volatile stocks — is HINOVA PHARMACEUTICALS INC. there?
Today HINOVA PHARMACEUTICALS INC. has the market capitalization of ‪3.75 B‬, it has decreased by −0.13% over the last week.
Yes, you can track HINOVA PHARMACEUTICALS INC. financials in yearly and quarterly reports right on TradingView.
688302 net income for the last quarter is ‪−53.66 M‬ CNY, while the quarter before that showed ‪−53.20 M‬ CNY of net income which accounts for −0.87% change. Track more HINOVA PHARMACEUTICALS INC. financial stats to get the full picture.
No, 688302 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 181.00 employees. See our rating of the largest employees — is HINOVA PHARMACEUTICALS INC. on this list?
Like other stocks, 688302 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HINOVA PHARMACEUTICALS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HINOVA PHARMACEUTICALS INC. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HINOVA PHARMACEUTICALS INC. stock shows the neutral signal. See more of HINOVA PHARMACEUTICALS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.